Globant (NYSE:GLOB) is under pressure after multiple law firms launched securities class actions over its Latin American business pivot, raising questions about disclosure practices and coinciding with a sharp share price pullback.

Legal headlines and the recent shelf registration have landed on a stock that was already under pressure, with a 30 day share price return of negative 15.11% and a 1 year total shareholder return of negative 66.01%. This points to fading momentum and a reset in risk perceptions around Globant’s story.

If the legal noise around one company has you rethinking concentration risk, it can be useful to cast the net wider and review 18 top founder-led companies

With Globant now trading at about US$40.62 after heavy drawdowns, a wide gap to analyst targets and some intrinsic value estimates has opened up. This raises the question: is this legal overhang creating a genuine entry point, or is the market correctly discounting future growth?

Most Popular Narrative: 44.6% Undervalued

At a last close of $40.62 versus a narrative fair value of $73.36, the most followed view suggests the market is heavily discounting Globant’s future cash flows.

The rapid adoption of AI and generative AI across industries is dramatically increasing the complexity of enterprise technology environments, driving greater demand for specialist partners to design, implement, and maintain tailored AI solutions. Globant's differentiated Enterprise AI platform, AI pods subscription model, and recent multiyear partnership wins (e.g., OpenAI, AWS) position the company to capture a greater share of this accelerating market. This may boost both revenue and margins over the long term as more high-value, recurring AI engagements convert in the pipeline.

Want to see what sits behind that confidence in future earnings and margins? The fair value hinges on a detailed mix of revenue growth, expanding profitability and the cash flow impact of those AI subscriptions.

Result: Fair Value of $73.36 (UNDERVALUED)

However, weak near term revenue guidance and questions over whether AI Pods can scale beyond 18 clients could easily challenge that upbeat earnings path.

Next Steps

Finding the balance between concern and optimism here is not simple, so act quickly, review the underlying data for yourself, and weigh up the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Globant's situation has sharpened your focus, do not stop there. Use this moment to scan for other opportunities that could better fit your risk and return preferences.

• Start with resilient balance sheets and consistent fundamentals by checking companies in the solid balance sheet and fundamentals stocks screener (44 results).
• Hunt for potential bargains where quality and price may be out of sync by reviewing the 51 high quality undervalued stocks.
• Prioritise stability with upside potential by scanning companies in the 70 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.